Tenax Therapeutics (TENX) Change in Inventory (2010 - 2014)
Tenax Therapeutics (TENX) posted quarterly Change in Inventory of -$97437.0 for Q2 2014, down 1215.61% year-over-year from $8734.0 in Q2 2013, and down 3163.13% on a QoQ basis from -$2986.0 in Q1 2014.
Tenax Therapeutics (TENX) Change in Inventory (2010 - 2014) Analysis & Trends
Tenax Therapeutics has reported Change in Inventory for 5 years, with the latest figure at -$97437.0 in Q2 2014.
- Change in Inventory for Q2 2014 came in at -$97437.0, down 1215.61% year-over-year; the trailing twelve-month figure through Dec 2015 was -$100423.0 (changed N/A YoY), and the FY2014 annual result was -$99204.0, down 390.43% from the prior year.
- Change in Inventory retreated to -$97437.0 in Q2 2014, from -$2986.0 in the prior quarter.
- Over five years, Change in Inventory peaked at $152048.0 in Q2 2011 and troughed at -$97437.0 in Q2 2014.
- A 5-year average of $6957.1 and a median of $1185.0 in 2013 frame the typical range for Change in Inventory.
- The widest annual swing landed in 2012, when Change in Inventory surged 111.37%; it then slumped 1215.61% in 2014.
- A 5-year view of Change in Inventory shows it stood at -$45572.0 in 2010, then advanced by 7.78% to -$42027.0 in 2011, then surged by 111.37% to $4780.0 in 2012, then sank by 80.1% to $951.0 in 2013, then plunged by 10345.74% to -$97437.0 in 2014.
- Per Business Quant data, the three most recent Change in Inventory figures were -$97437.0 in Q2 2014, -$2986.0 in Q1 2014, and $951.0 in Q4 2013.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.03 Bn | 131.18 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.64 Bn | 77.64 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 64.93 Bn | 59.75 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.93 Bn | 52.80 Bn | 52.00 Mn | 132.00 Mn |
| 5 | BeOne Medicines | 41.95 Bn | 36.86 Bn | 1.53 Bn | 47.15 Mn |
| 6 | Alnylam Pharmaceuticals | 31.51 Bn | 28.20 Bn | 992.69 Mn | -280,000.00 |
| 7 | BioNTech SE | 28.00 Bn | 9.60 Bn | 668.28 Mn | 135.26 Mn |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 12.97 Mn |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | - |
| 10 | Tenax Therapeutics | 78.30 Mn | 78.30 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2014 | -97,437.00 |
| Apr 30, 2014 | -97,437.00 |
| Jan 31, 2014 | -2,986.00 |
| Jan 31, 2014 | -2,986.00 |
| Oct 31, 2013 | 951.00 |
| Oct 31, 2013 | 951.00 |
| Jul 31, 2013 | 268.00 |
| Jul 31, 2013 | 268.00 |
| Apr 30, 2013 | 8,734.00 |
| Apr 30, 2013 | 8,734.00 |
| Jan 31, 2013 | 1,419.00 |
| Jan 31, 2013 | 1,419.00 |
| Oct 31, 2012 | 4,780.00 |
| Oct 31, 2012 | 4,780.00 |
| Jul 31, 2012 | -35,161.00 |
| Jul 31, 2012 | -35,161.00 |
| Apr 30, 2012 | 33,336.00 |
| Apr 30, 2012 | 33,336.00 |
| Jan 31, 2012 | -20,987.00 |
| Jan 31, 2012 | -20,987.00 |